HOME Canberra FM/CFS page Library contents page
Autonomic Function in CFS
Cognitive Function in CFS
Cardiovascular function and exercise in CFS
Prepared by Ellie Stein MD FRCP(C) from the
medical literature
July 2001
The autonomic nervous system affects virtually every aspect of body functioning. It regulates most involuntary functions such as heart rate (HR), blood pressure (BP) and gut and bladder function. Autonomic symptoms are not included in the diagnostic criteria of CFS. Never the less many CFS patients have clinical symptoms which suggest autonomic dysfunction. These include: increases heart rate, dizziness, fainting, delayed gastric emptying, urinary frequency and orthostatic intolerance.
Orthostatic intolerance refers to symptoms caused or worsened by standing. There are two types of OI. Neurally Mediated Hypotension (NMH) is a neurally mediated sudden drop in BP which causes fainting upon standing. Postural Orthostatic Tachycardia Syndrome (POTS) is an increase in HR of over 30 bpm from sitting to standing without loss of consciousness. The gold standard of diagnosis for OI is the onset of dizziness or fainting during tilt table testing.
Bou Holaigah et al from Johns Hopkins in 1995 were the first to note the connection between CFS and OI. They found that 22/23 CFS patients had abnormal responses on tilt table testing (Bou-Holaigah et al, 1995). Since then the finding of autonomic dysfunction has been validated as occurring in a subset of CFS patients.
Research findings include:
Possible mechanisms of orthostatic intolerance: The most likely mechanism for OI is decreased vascular tone in the periphery. Rowe has reported several cases of CFS in persons with Erlans Danlos syndrome a disorder of connective tissue elasticity associated with neurally mediated hypotension (NMH) as measured by tilt table testing (Rowe et al, 1999). Poor elasticity causes blood pooling in the peripheries and orthostatic intolerance.
The autonomic parasympathetic nervous system decreases vascular tone by through a cascade of events. The vagal signals activate muscarinic acetylcholine receptors on the endothelial cell surface. This activates G proteins, promoting the conversion of L-arginine to nitric oxide, which diffuses into the smooth muscle cells and stimulates guanylate cyclase to produce cyclic GMP, thereby causing relaxation. In the presence of excess NO vascular tone will be decreased and OI (either NMH or POTS) may result. Therefore the abnormality could occur at any point on this cascade
Most researchers are currently hypothesizing the problem lies with the cholinergic system. A recent report shows cholinergic supersensitivity in CFS (Spence et al, 2000). Work from the University of Newcastle (Australia) shows increases in serum concentrations of the amino acid ornithine in the serum of CFS patients. Ornithine varies with NO production (Dunstan et al, 2000). Therefore, increased ornithine correlates with increased NO activity. A recent report from the Mayo Clinic shows that some people with OI have antibodies which block the function of the ganglionic cholinergic receptors (Vernino et al, 2000).
Treatment: The treatment of choice for CFS patients with orthostatic intolerance is added salt and water. The amount of salt and water taken daily should be titrated to best health and blood pressure must be monitored during this treatment. The second line treatments for OI are florinef a salt saving hormone and midodrine a peripheral alpha (sympathetic) agonist. In some cases beta blockers or calcium channel blockers are helpful. Unfortunately all of the drug treatments for OI have side effects which can limit their use in CFS patients.
Bou-Holaigah,I., Rowe,P.C., Kan,J., & Calkins,H. (1995) The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA, 274, 961-967.
De Becker,P., Dendale,P., De Meirleir,K., Campine,I., Vandenborne,K., & Hagers,Y. (1998) Autonomic testing in patients with chronic fatigue syndrome. American Journal of Medicine, 105, 22S-26S.
De Lorenzo,F., Hargreaves,J., & Kakkar,V.V. (1997) Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome. Clinical Autonomic Research, 7, 185-190.
Dunstan,R.H., McGregor,N.R., Butt,H., Roberts,T.K., Klineberg,I.J., Niblett,S.H., Rothkirch,T., & Buttfield,I. (2000) Characterisation of differential amino acid homeostasis amongst population subgroups: a basis for determining specific amino acid requirements. Journal of Nutritional and Environmental Medicine.
Duprez,D.A., De Buyzere,M.L., Drieghe,B., Vanhaverbeke,F., Taes,Y., Michielsen, W, & Clement,D.L. (1998) Long- and short-term blood pressure and RR-interval variability and psychosomatic distress in chronic fatigue syndrome [see comments]. Clinical Science, 94, 57-63.
Freeman,R. & Komaroff,A.L. (1997) Does the chronic fatigue syndrome involve the autonomic nervous system? American Journal of Medicine, 102, 357-364.
Gibson,H., Carroll,N., Clague,J.E., & Edwards,H.T. (1993) Exercise performance and fatiguability in patients with chronic fatigue syndrome. Journal of Neurology, Neurosurgery & Psychiatry, 56, 993-998.
LaManca,J.J., Peckerman,A., Walker,J., Kesil,W., Cook,S., Taylor,A., Natelson, & BH. (1999) Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clinical Physiology, 19, 111-120.
Rowe,P.C., Barron,D.F., Calkins,H., Maumenee,I.H., Tong,P.Y., & Geraghty,M.T. (1999) Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. Journal of Pediatrics, 135, 494-499.
Soetekouw,P.M., Lenders,J.W., Bleijenberg,G., Thien,T., & van der Meer,J.W. (1999) Autonomic function in patients with chronic fatigue syndrome. Clinical Autonomic Research, 9, 334-340.
Spence,V.A., Khan,F., & Belch,J.F. (2000) Enhanced sensitivity of the peripheral cholinergic vascular response in patients with chronic fatigue syndrome. American Journal of Medicine, 108.
Stewart,J.M., Gewitz,M.H., Weldon,A., Arlievsky,N., Li,K., & Munoz,J. (1999) Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics, 103, 116-121.
van deLuit,L., van der,M.J., Cleophas,T.J., & Zwinderman,A.H. (1998) Amplified amplitudes of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not by melatonin. Angiology, 49, 903-908.
Vernino,S., Low,P.A., Fealey,R.D., Stewart,J.D., Farrugia,G., & Lennon,V.A. (2000) Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N.Engl.J.Med., 343, 847-855.
Yataco,A., Talo,H., Rowe,P., Kass,D.A., Berger,R.D., & Calkins,H. (1997) Comparison of heart rate variability in patients with chronic fatigue syndrome and controls. Clinical Autonomic Research, 7, 293-297.
Subjective cognitive dysfunction is a complaint of over 80% of patients with CFS and is a diagnostic criteria in all 4 of the extant working definitions.
What we know: Based on a thorough literature review it is agreed that persons with CFS (various definitions) show:
The cognitive deficit in CFS is not a structural one in any particular part of the brain. It is a functional disorder of information processing speed and efficiency. Emotional factors influence subjective report of cognitive difficulty, whereas their effect on objective performance remains uncertain. (Moss-Morris & Petrie, 1996;Tiersky et al, 1997)
Neuropsychological Findings:
Brain Imaging Findings:
Tests which most commonly discriminate CFS from controls:
Conclusions: As a group persons with CFS have measurable cognitive impairment which is made worse by physical exertion and cannot be attributed to comorbid conditions or attitudes. In individual patients cognitive deficits are difficult to prove with neuropsychiatric testing since there are rarely premorbid test results with which to compare. Never the less, findings which are out of keeping with known levels of premorbid functioning and decreased functioning after aerobic exercise are consistent with a diagnosis of CFS. Healthy controls and persons with depression generally do better on neuropsychiatric tests after exercise.
Barnden,L., Kitchener,M., Casse,R., Burnet,R., Delfante,P., & Kwiatek,R. Regional cerebral bloodflow in chronic fatigue syndrome (CFS). Unpublished presentation 2001.
Blackwood,S.K., MacHale,S.M., Power,M.J., Goodwin,G.M., & Lawrie,S.M. (1998) Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression. Journal of Neurology, Neurosurgery & Psychiatry, 65, 541-546.
Christodoulou,C., DeLuca,J., Lange,G., Johnson,S.K., Sisto,S.A., Korn,L., & Natelson,B.H. (1998) Relation between neuropsychological impairment and functional disability in patients with chronic fatigue syndrome. Journal of Neurology, Neurosurgery & Psychiatry, 64, 431-434.
Costa,D.C., Tannock,C., & Brostoff,J. (1995) Brainstem perfusion is impaired in chronic fatigue syndrome. QJM, 88, 767-773.
DeLuca,J., Johnson,S.K., Ellis,S.P., & Natelson,B.H. (1997) Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. Journal of Neurology, Neurosurgery & Psychiatry, 62, 151-155.
Fischler,B., D'Haenen,H., Cluydts,R., Michiels,V., Demets,K., Bossuyt,A., Kaufman,L., & De Meirleir,K. (1996) Comparison of 99m Tc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology, 34, 175-183.
Flor Henry,P.I., Lindl,J., Morrison,J., Pazderka-Robinson,H., & Kolas,Z. Chronic fatigue syndrome versus depression. 2001. ref Type: Unpublished Work
Johnson,S.K., DeLuca,J., Diamond,B.J., & Natelson,B.H. (1996) Selective impairment of auditory processing in chronic fatigue syndrome: a comparison with multiple sclerosis and healthy controls. Perceptual & Motor Skills, 83, 51-62.
Joyce,E., Blumenthal,S., & Wessely,S. (1996) Memory, attention, and executive function in chronic fatigue syndrome. Journal of Neurology, Neurosurgery & Psychiatry, 60, 495-503.
Kane,R.L., Gantz,N.M., & DiPino,R.K. (1997) Neuropsychological and psychological functioning in chronic fatigue syndrome. Neuropsychiatry, Neuropsychology, & Behavioral Neurology, 10, 25-31.
LaManca,J.J., Sisto,S.A., DeLuca,J., Johnson,S.K., Lange,G., Pareja,J., Cook,S., & Natelson,B.H. (1998) Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. American Journal of Medicine, 105, 59S-65S.
Michiels,V., Cluydts,R., Fischler,B., Hoffmann,G., Le Bon,O., & De Meirleir,K. (1996) Cognitive functioning in patients with chronic fatigue syndrome. Journal of Clinical & Experimental Neuropsychology, 18, 666-677.
Michiels,V., de,G., V, Cluydts,R., & Fischler,B. (1999) Attention and information processing efficiency in patients with Chronic Fatigue Syndrome. Journal of Clinical & Experimental Neuropsychology, 21, 709-729.
Moss-Morris,R. & Petrie,K.J. (1996) Functioning in Chronic Fatigue Syndrome: Do illness perceptions play a regulatory role? British Journal of Health Psychology, 1, 15-25.
Schmaling,K.B., DiClementi,J.D., Cullum,C.M., & Jones,J.F. (1994) Cognitive functioning in chronic fatigue syndrome and depression: a preliminary comparison. Psychosomatic Medicine, 56, 383-388.
Schwartz,R.B., Komaroff,A.L., Garada,B.M., Gleit,M., Doolittle,T.H., Bates,D.W., Vasile,R.G., & Holman,B.L. (1994) SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. AJR Am.J Roentgenol., 162, 943-951.
Tiersky,L.A., Johnson,S.K., Lange,G., Natelson,B.H., & DeLuca,J. (1997) Neuropsychology of chronic fatigue syndrome: a critical review. Journal of Clinical & Experimental Neuropsychology, 19, 560-586.
Tirelli,U., Chierichetti,F., Tavio,M., Simonelli,C., Bianchin,G., Zanco,P., & Ferlin,G. (1998) Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. American Journal of Medicine, 105, 54S-58S.
Vercoulen,J.H., Bazelmans,E., Swanink,C.M., Galama,J.M., Fennis,J.F., van,d., Meer,J.W., & Bleijenberg,G. (1998) Evaluating neuropsychological impairment in chronic fatigue syndrome. Journal of Clinical & Experimental Neuropsychology, 20, 144-156.
An Overview of Exercise Physiology
Most patients with CFS complain of decreased exercise tolerance compared to their premorbid condition. As well they report prolonged fatigue after exercise that was previously well within their ability. Using a standard treadmill or bicycle model subjects are asked to slowly increase exertion to their maximum level. During this time measures of cardiovascular, pulmonary and metabolic function can be taken.
Oxygen ventilation rates per minute per kg body weight (VO2max) is the most commonly used indicator of oxidative capacity/fitness. VO2max depends upon cardiac output, pulmonary function and the muscle's ability to extract O2. In healthy people the cardiac output (CO) is the limiting factor. O2 uptake increases linearly with increasing exercise until a plateau is reached this is maximal work intensity. VO2max can also be estimated by peak HR (220 - age). The VO2max in healthy adults ranges from 25-35ml/min/kg (Lewis & Haller, 1991). At < 50% VO2max fatty acids are the predominant fuel, above 50% VO2max glycogen is the dominant fuel.
At a VO2max of 70-80% anaerobic metabolism is required to maintain activity level. This is marked by lactic acid accumulation which can be measured in the venous blood and a decrease in intracellular pH which can be measured by magnetic spectroscopy.
Exercise Findings in CFS
Most well designed, large studies show that PWCs have significantly lower fitness level than well matched sedentary controls (De Becker et al, 2000;Fulcher & White, 2000;Sisto et al, 1996; Rowbottom et al, 1998;Riley et al, 1990). PWCs tolerate a shorter duration of exercise and some cannot finish the protocol. Specific findings include:
Related Findings:
Of Note:
Is Deconditioning an Etiological Factor in CFS?
There is substantial evidence that PWCs are deconditioned compared with their premorbid conditions. What remains controversial is whether deconditioning is a normal and expected response to decreased activity due to chronic illness or whether deconditioning is in fact causes or perpetuates CFS. Proponents of the first hypothesis note that PWCs are already functioning at their maximal energy ability (Friedberg & Krupp, 1994;Lapp, 1997). They note that both physical and mental exertion cause a temporary decline in functioning in persons with CFS (Paul et al, 1999;Levine et al, 1997;Blackwood et al, 1998).
The proponents of the deconditioning theory of CFS conclude that because PWCs are out of shape, that deconditioning is a causal factor. A recent study disproved this hypothesis (Bazelmans et al, 2001). There are two studies specifically assessing the effects of graded exercise in CFS. One with highly selected, mild and moderately ill patients showed improvement in fatigue levels with mild graduated exercise but the outcome was unrelated to increasing fitness. Like many treatment studies in CFS, the authors did not report on any physical symptoms of CFS (Fulcher & White, 1997). The other study had a high drop out rate in the exercise group and equivocal findings (Wearden et al, 1998). Despite the lack of evidence of benefit, several official bodies recommend graded exercise as a treatment of choice for CFS.
Bazelmans,E., Bleijenberg,G., van der Meer,J.W., & Folgering,H. (2001) Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity. Psychological Medicine , 31, 107-114.
Blackwood,S.K., MacHale,S.M., Power,M.J., Goodwin,G.M., & Lawrie,S.M. (1998) Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression. Journal of Neurology, Neurosurgery & Psychiatry, 65, 541-546.
De Becker,P., Roeykens,J., Reynders,M., McGregor,N.R., & De Meirleir,K. (2000) Exercise capacity in chronic fatigue syndrome. PhD Thesis, Vrije Universiteit Brussel.
Friedberg,F. & Krupp,L.B. (1994) A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clinical Infectious Diseases, 18 Suppl 1, S105-S110.
Fulcher,K.Y. & White,P.D. (1997) Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ, 314, 1647-1652.
Fulcher,K.Y. & White,P.D. (2000) Strength and physiological response to exercise in patients with chronic fatigue syndrome. J NEUROL NEUROSUR, 69, 302-307.
Gibson,H., Carroll,N., Clague,J.E., & Edwards,H.T. (1993) Exercise performance and fatiguability in patients with chronic fatigue syndrome. Journal of Neurology, Neurosurgery & Psychiatry, 56, 993-998.
Lapp,C.W. (1997) Exercise limits in chronic fatigue syndrome. American Journal of Medicine, 103, 83-84.
Lerner,A.M., Lawrie,C., & Dworkin,H.S. (1993) Repetitively negative changing T waves at 24-h electrocardiographic monitors in patients with the chronic fatigue syndrome. Left ventricular dysfunction in a cohort. Chest, 104, 1417-1421.
Levine,P.H., Snow,P.G., Ranum,B.A., Paul,C., & Holmes,M.J. (1997) Epidemic neuromyasthenia and chronic fatigue syndrome in west Otago, New Zealand. A 10-year follow-up. Archives of Internal Medicine, 157, 750-754.
Lewis,S.F. & Haller,R.G. (1991) Physiologic measurement of exercise and fatigue with special reference to chronic fatigue syndrome. Reviews of Infectious Diseases, 13 Suppl 1, S98-108.
McCully,K.K. & Natelson,B.H. (1999) Impaired oxygen delivery to muscle in chronic fatigue syndrome . Clinical Science, 97, 603-608.
Paul,L., Wood,L., Behan,W.M., & Maclaren,W.M. (1999) Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome. European Journal of Neurology, 6, 63-69.
Riley,M.S., O'Brien,C.J., McCluskey,D.R., Bell,N.P., Nicholls, & DP. (1990) Aerobic work capacity in patients with chronic fatigue syndrome. BMJ, 301, 953-956.
Rowbottom,D., Keast,D., Pervan,Z., & Morton,A. (1998) The physiological response to exercise in chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome, 4.
Sisto,S.A., LaManca,J., Cordero,D.L., Bergen,M.T., Ellis,S.P., Drastal,S., Boda,W.L., Tapp,W.N., & Natelson,B.H. (1996) Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome [see comments]. American Journal of Medicine, 100, 634-640.
Wearden,A.J., Morriss,R.K., Mullis,R., Strickland,P.L., Pearson,D.J., Appleby,L., Campbell,I.T., & Morris,J.A. (1998) Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome [see comments] [published erratum appears in Br J Psychiatry 1998 Jul;173:89]. British Journal of Psychiatry, 172, 485-490.
Wong,R., Lopaschuk,G., Zhu,G., Walker,D., Catellier,D., Burton,D., Teo,K., Collins-Nakai,R., & Montague,T. (1992) Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest, 102, 1716-1722.
Eleanor Stein MD FRCP(C)
Psychiatrist
Burke Institute for the Rehabilitation of Chronic Illness
Suite G100 Holy Cross Centre
2210 - 2nd St. SW
Calgary Alberta
T2S 3C3 Canada
Phone (403) 802-1772
FAX (not yet installed) (403) 802-1762
email: cdnpsych@telusplanet.net
![]()
BACK HOME to the Canberra Fibromyalgia and Chronic Fatigue
Syndrome Page
http://www.masmith.inspired.net.au/
Webmaster: Moira A Smith last revised 29 July, 2001